Alector, Inc. (ALEC): Price and Financial Metrics
ALEC Price/Volume Stats
Current price | $6.13 | 52-week high | $9.06 |
Prev. close | $6.08 | 52-week low | $3.66 |
Day low | $5.95 | Volume | 55,695 |
Day high | $6.13 | Avg. volume | 694,496 |
50-day MA | $6.28 | Dividend yield | N/A |
200-day MA | $6.35 | Market Cap | 586.94M |
ALEC Stock Price Chart Interactive Chart >
Alector, Inc. (ALEC) Company Bio
Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA
Latest ALEC News From Around the Web
Below are the latest news stories about ALECTOR INC that investors may wish to consider to help them evaluate ALEC as an investment opportunity.
How The Same Treatments May Work For Multiple Neurodegenerative DiseasesExtensive research on NDDs has uncovered a different treatment pathway that's enabling some biotechnology firms to target more than one NDD with the same drug candidate. |
ALEC Price Returns
1-mo | -12.55% |
3-mo | -23.18% |
6-mo | -5.40% |
1-year | -2.85% |
3-year | -64.09% |
5-year | -67.25% |
YTD | -23.18% |
2023 | -13.54% |
2022 | -55.30% |
2021 | 36.48% |
2020 | -12.19% |
2019 | N/A |
Loading social stream, please wait...